FR2384504A1 - Pancreas endocrine artificiel - Google Patents

Pancreas endocrine artificiel

Info

Publication number
FR2384504A1
FR2384504A1 FR7808199A FR7808199A FR2384504A1 FR 2384504 A1 FR2384504 A1 FR 2384504A1 FR 7808199 A FR7808199 A FR 7808199A FR 7808199 A FR7808199 A FR 7808199A FR 2384504 A1 FR2384504 A1 FR 2384504A1
Authority
FR
France
Prior art keywords
endocrine pancreas
daltons
artificial endocrine
passage
housing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7808199A
Other languages
English (en)
Other versions
FR2384504B1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Pasteur Ltd
Original Assignee
Connaught Laboratories Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Connaught Laboratories Ltd filed Critical Connaught Laboratories Ltd
Publication of FR2384504A1 publication Critical patent/FR2384504A1/fr
Application granted granted Critical
Publication of FR2384504B1 publication Critical patent/FR2384504B1/fr
Granted legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/022Artificial gland structures using bioreactors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/14Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
    • A61M1/16Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis with membranes
    • A61M1/1621Constructional aspects thereof
    • A61M1/1623Disposition or location of membranes relative to fluids
    • A61M1/1627Dialyser of the inside perfusion type, i.e. blood flow inside hollow membrane fibres or tubes

Landscapes

  • Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Transplantation (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Cardiology (AREA)
  • Emergency Medicine (AREA)
  • Anesthesiology (AREA)
  • Hematology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • External Artificial Organs (AREA)

Abstract

L'invention concerne un pancréas endocrine artificiel. Ce dispositif est constitué d'un logement qui contient une ou plusieurs fibres creuses avec des cellules d'îlots pancréatiques entre le logement et l'extérieur des fibres, chaque fibre ayant une pososité permettant le passage des substances ayant un poids moléculaire inférieur à 100.000 daltons, si bien que le sang passant dans les fibres creuses peut fournir des substances nutritives aux cellules et s'enrichir en hormones sans qu'il y ait de passage d'antigènes ou d'anticorps ayant un poids moléculaire superieur à 100.000 daltons. L'invention s'applique en particulier au traitement ambulatoire du diabète.
FR7808199A 1977-03-21 1978-03-21 Pancreas endocrine artificiel Granted FR2384504A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CA274,354A CA1085104A (fr) 1977-03-21 1977-03-21 Pancreas endocrine artificiel

Publications (2)

Publication Number Publication Date
FR2384504A1 true FR2384504A1 (fr) 1978-10-20
FR2384504B1 FR2384504B1 (fr) 1985-02-22

Family

ID=4108204

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7808199A Granted FR2384504A1 (fr) 1977-03-21 1978-03-21 Pancreas endocrine artificiel

Country Status (5)

Country Link
US (1) US4323457A (fr)
CA (1) CA1085104A (fr)
DE (1) DE2811372A1 (fr)
FR (1) FR2384504A1 (fr)
GB (1) GB1576590A (fr)

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0059694A1 (fr) * 1981-02-26 1982-09-08 Aktiebolaget Hässle Dispositif d'administration de produits pharmaceutiques
WO1987003802A2 (fr) * 1985-12-20 1987-07-02 Schrezenmeir Juergen Dispositif et instrument de reception et d'introduction de tissus dans le corps humain
WO1991002498A1 (fr) * 1989-08-25 1991-03-07 W.R. Grace & Co.-Conn. Dispositif de perfusion pancreatique artificiel
US5116493A (en) * 1989-08-25 1992-05-26 W. R. Grace & Co.-Conn. Artificial pancreatic perfusion device with reseedable matrix
US5116494A (en) * 1989-08-25 1992-05-26 W. R. Grace & Co.-Conn. Artificial pancreatic perfusion device with temperature sensitive matrix
WO2012010767A1 (fr) 2010-07-22 2012-01-26 Statice Sante Poche pour former un organe artificiel implantable
EP3428264A1 (fr) 2017-07-12 2019-01-16 Defymed Poche non pliable pour former un organe artificiel implantable

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4787974A (en) * 1981-06-29 1988-11-29 Ambrus Clara M Blood purification
US4714556A (en) * 1981-06-29 1987-12-22 Ambrus Clara M Blood purification
US4740198A (en) * 1981-10-09 1988-04-26 Alza Corporation Method of administering intravenous drug using rate-controlled dosage form
US4973307A (en) * 1981-07-13 1990-11-27 Alza Corporation Method for administering drugs to a patient
US5069671A (en) * 1981-07-13 1991-12-03 Alza Corporation Intravenous medication
USRE34365E (en) * 1981-07-13 1993-08-31 Intravenous system for delivering a beneficial agent
US4985017A (en) * 1981-07-13 1991-01-15 Alza Corporation Parenteral therapeutical system comprising drug cell
US4790820A (en) * 1981-07-13 1988-12-13 Alza Corporation Parenteral agent dispensing equipment with drug releasing member
US4994031A (en) * 1981-07-13 1991-02-19 Alza Corporation Intravenous system for delivering a beneficial agent
US4740201A (en) * 1981-10-09 1988-04-26 Alza Corporation Intravenous system for delivering a beneficial agent
US4857052A (en) * 1981-07-13 1989-08-15 Alza Corporation Intravenous system for delivering a beneficial agent
US4871360A (en) * 1981-07-31 1989-10-03 Alza Corporation System for intravenous delivery of a beneficial drug at a regulated rates
US4740199A (en) * 1981-10-09 1988-04-26 Alza Corporation Intravenous system for delivering a beneficial agent
US4741735A (en) * 1981-10-09 1988-05-03 Alza Corporation Intravenous system for delivering a beneficial agent
US4741734A (en) * 1981-10-09 1988-05-03 Alza Corporation Releasing means for adding agent using releasing means to IV fluid
US4740197A (en) * 1981-10-09 1988-04-26 Alza Corporation Intravenous system for delivering a beneficial agent via polymer delivery
US4740103A (en) * 1981-10-09 1988-04-26 Alza Corporation Intravenous system for delivering a beneficial agent
US4586922A (en) * 1981-10-09 1986-05-06 Alza Corporation Intravenous system for delivering a beneficial agent
US4740200A (en) * 1981-10-09 1988-04-26 Alza Corporation Intravenous system for delivering a beneficial agent
US4579553A (en) * 1981-11-27 1986-04-01 Alza Corporation Parenteral controlled therapy
US4552556A (en) * 1981-11-27 1985-11-12 Alza Corporation Parenteral controlled therapy
US4583981A (en) * 1981-11-27 1986-04-22 Alza Corporation Parenteral controlled therapy, using a porous matrix with parenteral agent
US4908019A (en) * 1982-05-24 1990-03-13 Alza Corporation Apparatus comprising dual reservoirs for parenteral infusion of fluid containing beneficial agent
FR2531333B1 (fr) * 1982-08-09 1986-04-04 Centre Nat Rech Scient Pancreas bio-artificiel a ultrafiltration
JPS5980238A (ja) * 1982-09-24 1984-05-09 ジ−ン−ベルナルド・ブチス 複合人工器官用装具
US4511352A (en) * 1984-05-14 1985-04-16 Alza Corporation Parenteral delivery system with in-line container
US4596555A (en) * 1984-05-14 1986-06-24 Alza Corporation Parenteral delivery system utilizing a hollow fiber cellular unit
US4511351A (en) * 1984-05-14 1985-04-16 Alza Corporation Parenteral delivery system utilizing a hollow fiber cellular unit
JPS61209010A (ja) * 1985-03-12 1986-09-17 Toyo Soda Mfg Co Ltd 微量液体フイルタ−
US4846977A (en) * 1986-10-21 1989-07-11 The Dow Chemical Company Method and device for separating polar from non-polar liquids using membranes
US4902416A (en) * 1987-11-20 1990-02-20 The Dow Chemical Company Membrane separation device
US5413601A (en) * 1990-03-26 1995-05-09 Keshelava; Viktor V. Tubular organ prosthesis
US5314472A (en) * 1991-10-01 1994-05-24 Cook Incorporated Vascular stent
CA2147626C (fr) 1993-08-10 1998-04-21 Mark D. Butler Dispositif d'encapsulation de cellules
US5626758A (en) 1995-08-08 1997-05-06 Rensselaer Polytechnic Institute Coiled membrane filtration system
US5702444A (en) * 1995-09-11 1997-12-30 Struthers, Mehta And Maxwell Implantable artificial endocrine pancreas
WO1999022851A1 (fr) * 1997-11-04 1999-05-14 Millipore Corporation Dispositif de filtration a membrane
US6365385B1 (en) 1999-03-22 2002-04-02 Duke University Methods of culturing and encapsulating pancreatic islet cells
US6303355B1 (en) 1999-03-22 2001-10-16 Duke University Method of culturing, cryopreserving and encapsulating pancreatic islet cells
EP1234553A1 (fr) * 2001-02-14 2002-08-28 Boris-Wolfgang Hochleitner Dispositif bioartificiel
DE502004004962D1 (de) * 2003-06-23 2007-10-25 Fraunhofer Ges Forschung Verfahren zur differenzierung von stammzellen in zellen, die ein pankreatisches hormon produzieren
DE102004011400A1 (de) * 2004-03-05 2005-09-22 Cavis Microcaps Gmbh Technischer Prozess sowie Anlage zur Gewinnung und/oder Verkapselung von lebenden Zellen aus Organen
US9788978B2 (en) * 2004-12-20 2017-10-17 Nicholas A. Rojo Implantable systems and stents containing cells for therapeutic uses
FR2960783B1 (fr) 2010-06-04 2012-07-27 Ass Pour Les Transferts De Technologies Du Mans Membrane fonctionnalisee pour chambre d'encapsulation de cellules produisant au moins une substance d'interet therapeutique et organe bioartificiel comprenant une telle membrane
US20210093435A1 (en) 2019-09-27 2021-04-01 Isla Technologies, Inc. Bioartificial pancreas
WO2022047543A1 (fr) * 2020-09-04 2022-03-10 Captix Biomedical Pty Ltd Implant osseux
JP2024515224A (ja) * 2021-04-27 2024-04-05 サノフイ 第1および第2の孔を有する容器の壁を有する治療デバイスおよびシステムの製造

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3388803A (en) * 1965-04-16 1968-06-18 Applied Biolog Sciences Lab In Wearable dialysis apparatus
US3734851A (en) * 1969-12-29 1973-05-22 K Matsumura Method and device for purifying blood
US3742946A (en) * 1970-05-15 1973-07-03 C Grossman Apparatus for the in vivo treatment of blood containing harmful components resulting from chronic uremia and other conditions
FR2270895A1 (fr) * 1974-05-17 1975-12-12 Community Blood Council Greate
GB1479002A (en) * 1973-06-06 1977-07-06 Spielberg T Artificial gland structure

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE608328A (fr) * 1960-09-19
US3396849A (en) * 1966-05-10 1968-08-13 Univ Minnesota Membrane oxygenator-dialyzer
BE793624A (fr) * 1972-01-10 1973-05-02 Baxter Laboratories Inc Dispositif pour le transfert de masses, presentant une membrane de diffision tubulaire enroulee
US3935118A (en) * 1973-03-05 1976-01-27 Philip A. Hunt Chemical Corporation Nitric acid system for etching magnesium plates
JPS5228519B2 (fr) * 1973-09-19 1977-07-27
US3902490A (en) * 1974-03-27 1975-09-02 Univ Utah Portable artificial kidney system
US3951147A (en) * 1975-04-07 1976-04-20 Metal Bellows Company Implantable infusate pump

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3388803A (en) * 1965-04-16 1968-06-18 Applied Biolog Sciences Lab In Wearable dialysis apparatus
US3734851A (en) * 1969-12-29 1973-05-22 K Matsumura Method and device for purifying blood
US3742946A (en) * 1970-05-15 1973-07-03 C Grossman Apparatus for the in vivo treatment of blood containing harmful components resulting from chronic uremia and other conditions
GB1479002A (en) * 1973-06-06 1977-07-06 Spielberg T Artificial gland structure
FR2270895A1 (fr) * 1974-05-17 1975-12-12 Community Blood Council Greate

Cited By (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0059694A1 (fr) * 1981-02-26 1982-09-08 Aktiebolaget Hässle Dispositif d'administration de produits pharmaceutiques
WO1987003802A2 (fr) * 1985-12-20 1987-07-02 Schrezenmeir Juergen Dispositif et instrument de reception et d'introduction de tissus dans le corps humain
WO1987003802A3 (fr) * 1985-12-20 1987-07-30 Juergen Schrezenmeier Dispositif et instrument de reception et d'introduction de tissus dans le corps humain
WO1991002498A1 (fr) * 1989-08-25 1991-03-07 W.R. Grace & Co.-Conn. Dispositif de perfusion pancreatique artificiel
US5116493A (en) * 1989-08-25 1992-05-26 W. R. Grace & Co.-Conn. Artificial pancreatic perfusion device with reseedable matrix
US5116494A (en) * 1989-08-25 1992-05-26 W. R. Grace & Co.-Conn. Artificial pancreatic perfusion device with temperature sensitive matrix
WO2012010767A1 (fr) 2010-07-22 2012-01-26 Statice Sante Poche pour former un organe artificiel implantable
US8834979B2 (en) 2010-07-22 2014-09-16 Statice Sante Bag for forming an implantable artificial organ
EP3428264A1 (fr) 2017-07-12 2019-01-16 Defymed Poche non pliable pour former un organe artificiel implantable
WO2019011939A1 (fr) 2017-07-12 2019-01-17 Defymed Poche non pliable pour former un organe artificiel implantable

Also Published As

Publication number Publication date
FR2384504B1 (fr) 1985-02-22
DE2811372A1 (de) 1978-11-02
US4323457A (en) 1982-04-06
CA1085104A (fr) 1980-09-09
GB1576590A (en) 1980-10-08

Similar Documents

Publication Publication Date Title
FR2384504A1 (fr) Pancreas endocrine artificiel
Guth et al. The enigma of central nervous regeneration. Summarized transactions of a conference on applications of new technology to the enigma of central nervous regeneration, held in Palm Beach, Florida, February 4-6, 1970 under the auspices of the National Paraplegia Foundation
ATE113817T1 (de) Künstliche bauchspeicheldrüsenperfundierungsvorrichtung.
DE3886046D1 (de) Sich selbst stumpf machende nadeleinheit sowie diese aufweisende vorrichtung.
ES2166866T3 (es) Deteccion de predisposicion genetica a enfermedad periodontal.
FR2414053A1 (fr) Pseudo-haptenes et leur procede de preparation
FR2696938B1 (fr) Méthodes et assemblage de traitement d'un fluide biologique.
ES2064262R (fr)
DE69824234D1 (de) Menschliche-"CDR-grafted"-Antikörper gegen Gangliosid gm2
CA2167650A1 (fr) Composition de teinture d'oxydation des fibres keratiniques et procede de teinture mettant en oeuvre cette composition
FR2368147A2 (fr) Filtres pour photodetecteurs
Barraud Kei society and the person: an approach through childbirth and funerary rituals
DE69006166D1 (de) Verstärker für Nachrichtenübertragungsleitungen aus optischen Fasern und Nachrichtenübertragungsleitungen aus optischen Fasern mit diesem Verstärker.
SE9202428D0 (sv) Inlaegg, inlaeggsbaerare och foerfarande foer tandrestaurering samt tandrestaureringsset foer genomfoerande av foerfarandet
Rao Religion and intensity of inbreeding in Tamil Nadu, South India
DE68927640D1 (de) Autonome, visuell anziehende Vorrichtung mit einem über den Kanten beleuchteten Paneel
Avichezer et al. PA‐II, the L‐fucose and D‐mannose binding lectin of Pseudomonas aeruginosa stimulates human peripheral lymphocytes and murine splenocytes
ES2108104T3 (es) Producto de aposito con anima de fibras de alginato.
Hayden Ecosystem valuation: combining economics, philosophy, and ecology
Oliveira et al. A sensitive method for assaying chemotaxic responses of Leishmania promastigotes
Basili et al. A perilous migration.
Dil Worth Hopkins' the Starlight Night
Valde-Nowak Jan Machnik (1930–2023). A scholar at a crossroads
Phillips Back contamination.
Crum Bestia, Tripterocladium, and Isothecium: an explication of relationships

Legal Events

Date Code Title Description
ST Notification of lapse